SCD and metabolic dysfunction-associated steatohepatitis: SCD also known as SCD1, was estimated to be higher in NASH patients than in patients with normal liver function (52), while SCD expression was increased in HFD-induced NASH mice (Figure 8G), suggesting that high SCD activity is associated with NASH.